Samsung Introduces Clinical Values of Its AI Diagnostic Solutions at ISUOG World Congress 2022
Samsung demonstrates real-time ultrasound image sharing with SonoSyncTM and introduces the recently launched high-end ultrasound system ‘V7’
Samsung Medison, a global medical equipment company and an affiliate of Samsung Electronics, will be participating at the ISUOG (International Society of Ultrasound in Obstetrics and Gynecology) World Congress 2022 held in London, U.K., from September 16th through September 18th.
During this congress, Samsung will be showcasing the clinical values and efficiencies of artificial intelligence (AI)-based diagnostic solutions through various scientific programs.
Samsung’s symposium will be held on September 18th at 12:35 p.m. This event will also run online under the theme of “Samsung’s Advanced AI and Remote Diagnosis Solutions.” Prof. Julien Stirnemann (Necker Hospital, France) will deliver research results on the clinical values of two AI diagnostic solutions:
BiometryAssistTM, which measures the growth and condition of a fetus, and HeartAssistTM, which improves workflow when diagnosing a fetal heart,
Professor Antonia Testa (Scientific Director of the Center for Ultrasound in Gynecological Oncology “Class Ultrasound” of the Agostino Gemelli University Hospital, Rome, Italy) will be demonstrating her experience with SonoSyncTM, a real-time ultrasound image-sharing solution, during Samsung’s Symposium. She will be presenting the simplicity and benefits of image sharing as a second opinion by remotely accessing a HERA W10 system at Gemelli Hospital, Rome, from the ISUOG venue in London.
“This will be a live demonstration of a patient scan, voice communication with a sonographer, and remote measurements executed in London. This advancement in the the ultrasound environment using SonoSyncTM brings telesonography into reality,” said Professor Antonia Testa. “I believe Samsung’s forward-thinking technologies and advanced developments in ultrasound in recent years are quite impressive.”
In addition, Samsung will be hosting four onsite Hospitality Suite programs with lectures and live demonstrations for customers to experience high-performance diagnostic solutions such as MV-FlowTM, which is used to visualize the slow flow of microvascular structures and the existence of micro-blood flow.
The onsite scientific program, Samsung, will display online webinars six times during the congress through ISUOG’s virtual platform. More details on Samsung’s scientific programs can be found on the ISUOG website and Samsung’s Healthcare website (www.samsunghealthcare.com).
Samsung will also showcase its premium ultrasound system for obstetrics and gynecology, known as HERA W10. The HERA W10 system includes Intelligent Assist (AI diagnostic solutions), as well as V8 and V7, two high-end ultrasound systems that can be used in various medical specialties and also with premium AI diagnostic solutions.
As far as the name goes, the “V” in “V7” stands for “Versatile,” meaning that this system can be used in various medical fields such as obstetrics, gynecology, radiology, orthopedics, cardiology, and more. The V7 hosts features and solutions seen on premium ultrasound systems.
※ The diagnostic solutions provided with V8 and V7 are the same, but there are some differences in their image resolution.
Kyu Tae Yoo, Senior Vice President, Head of Sales & Marketing Team of Samsung Medison, stated, “This is a very meaningful time for us as we share the clinical values of our ultrasound AI-based diagnostic tools and features in collaboration with so many prominent medical professionals.
We will continuously proceed forward, introducing diagnostic solutions for medical professionals and patients.”
For more information on Samsung’s Healthcare division, its subsidiaries, and products, please visit https://www.samsunghealthcare.com.